Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial
Baize, Nathalie, Monnet, Isabelle, Greillier, Laurent, Geier, Margaux, Lena, Hervé, Janicot, Henri, Vergnenegre, Alain, Crequit, Jacky, Lamy, Regine, Auliac, Jean-Bernard, Letreut, Jacques, Le Caer,Volume:
21
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(20)30461-7
Date:
September, 2020
File:
PDF, 68 KB
2020